PEDIATRICS Vol. 108 No. 5 November 2001, p. e93
Received Mar 5, 2001; accepted Jun 28, 2001.
,
,
From the * Department of Hematology/Oncology, Children's
Hospitals and Clinics Objective. Eosinophil-associated
proteins, especially eosinophil-derived neurotoxin, may be important
contributors to the neurologic pathology and symptoms caused by
Baylisascaris procyonis infection.
Methods. Two cases of severe B procyonis
encephalitis with evidence of marked eosinophil degranulation in the
central nervous system are presented. Serial cerebrospinal fluid (CSF)
specimens were collected from each patient during the course of their
illness. Antibodies against B procyonis were measured in
the patients' serum and CSF. Levels of the eosinophilopoietin
interleukin-5 (IL-5) and 2 important eosinophil proteins,
eosinophil-derived neurotoxin and major basic protein, were assayed in
the CSF.
Results. Both patients had rapidly progressive central
nervous system disease with evidence of eosinophilic
meningoencephalitis. Both tested positive for antibodies to B
procyonis in serum and CSF and had progressively worsening deep
white matter changes on magnetic resonance images of the brain. CSF
levels of IL-5, eosinophil-derived neurotoxin, and major basic protein
were markedly elevated over controls.
Conclusions. This is the first report of the measurement
of IL-5, eosinophil-derived neurotoxin, and major basic protein in
human CSF. In addition to traumatic damage and necrosis caused by
migrating larvae, eosinophil-derived neurotoxin from associated
eosinophilic inflammation may be an important contributory factor in
the pathogenesis of B procyonis encephalitis.
parasite, eosinophil-derived-neurotoxin, major basic protein,
eosinophilia, hypereosinophilia, interleukin-5, encephalitis, child.
St Paul, St Paul, Minnesota;
Department of
Veterinary Pathobiology, Purdue University, School of Veterinary
Medicine, West Lafayette, Indiana; § Division of Allergy and Outpatient
Infectious Diseases and
Department of Internal Medicine and
Immunology, Mayo Clinic and Foundation, Rochester, Minnesota.
This article has been cited by other articles:
![]() |
P. J. Gavin, K. R. Kazacos, and S. T. Shulman Baylisascariasis Clin. Microbiol. Rev., October 1, 2005; 18(4): 703 - 718. [Abstract] [Full Text] [PDF] |
||||